Informations générales (source: ClinicalTrials.gov)
Use of the Rhytmia System for Determining the Precise Location and Potential Mechanism of Premature Ventricular Contractions (RhytmiaPVC)
Observational
University Hospital, Toulouse (Voir sur ClinicalTrials)
juin 2017
juin 2019
29 juin 2024
This is a purely observational project and the objectives are to record and analyze the
local potentials at the site of Premature Ventricular Contraction (VPC) focus through the
Rhythmia system, ti determine the short and long-term success of the procedure and
compare it to the existing literature about standard procedures, to highlight the
advantages of the system compared to conventional mapping and to characterize optimal
pace map or activation map as achieved by the Rhythmia system.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
University Hospital Toulouse - 31059 - Toulouse - France | Philippe Maury, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- patients with symptomatic monomorphic PVC with or without heart disease refractory
to anti arrhythmic drugs
- patients with dilated cardiomyopathy and altered Left Ventricular Ejection Fraction
(LVEF) suspected to be causes by frequent monomorphic VPC
- patients with malignant ventricular arrhythmias reproducibly induced by monomorphic
PVC
- patients with symptomatic monomorphic PVC with or without heart disease refractory
to anti arrhythmic drugs
- patients with dilated cardiomyopathy and altered Left Ventricular Ejection Fraction
(LVEF) suspected to be causes by frequent monomorphic VPC
- patients with malignant ventricular arrhythmias reproducibly induced by monomorphic
PVC
- patients with non-symptomatic VPC and without cardiomyopathy
- patients under 18 yo
- pregnant women
- patients with polymorphic PVC arising from clearly different areas
- patient protected by the french law: guardianship and Trusteeship